# PIPAC and FOLFOX for Gastric Cancer Peritoneal Cancer

> **NCT05644249** · NA · COMPLETED · sponsor: **Vilnius University** · enrollment: 37 (actual)

## Conditions studied

- Gastric Cancer
- Peritoneal Carcinomatosis

## Interventions

- **DRUG:** Combined Doxorubicin and Cisplatin Pressurized IntraPeritoneal Aerosol Chemotherapy With Systemic FOLFOX chemotherapy

## Key facts

- **NCT ID:** NCT05644249
- **Lead sponsor:** Vilnius University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-01
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-09-01
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2025-09-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05644249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05644249, "PIPAC and FOLFOX for Gastric Cancer Peritoneal Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05644249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*